Effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of pregnancy.
D002250:Carbon Radioisotopes; D003338:Corpus Luteum / Q000187:drug effects / Q000378:metabolism*; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008234:Lynestrenol / Q000494:pharmacology; D008525:Medroxyprogesterone / Q000494:pharmacology; D008535:Megestrol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology; D009644:Norgestrel / Q000494:pharmacology; D011247:Pregnancy; D011284:Pregnenolone / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis* / Q000494:pharmacology; D045167:Progesterone Congeners / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D045167:Progesterone Congeners; D009644:Norgestrel; D011374:Progesterone; D011284:Pregnenolone; D009641:Norethynodrel; D008535:Megestrol; D008525:Medroxyprogesterone; D008234:Lynestrenol; D009640:Norethindrone